These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 20051832)

  • 21. Impact of left ventricular assist device bridging on posttransplant outcomes.
    Pal JD; Piacentino V; Cuevas AD; Depp T; Daneshmand MA; Hernandez AF; Felker GM; Lodge AJ; Rogers JG; Milano CA
    Ann Thorac Surg; 2009 Nov; 88(5):1457-61; discussion 1461. PubMed ID: 19853092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of left ventricular assist device infection on post-transplant outcomes.
    Schulman AR; Martens TP; Russo MJ; Christos PJ; Gordon RJ; Lowy FD; Oz MC; Naka Y
    J Heart Lung Transplant; 2009 Mar; 28(3):237-42. PubMed ID: 19285614
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of the percutaneous left ventricular assist device in patients with severe refractory cardiogenic shock as a bridge to long-term left ventricular assist device implantation.
    Idelchik GM; Simpson L; Civitello AB; Loyalka P; Gregoric ID; Delgado R; Kar B
    J Heart Lung Transplant; 2008 Jan; 27(1):106-11. PubMed ID: 18187095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thoratec implantable ventricular assist device: the Papworth experience.
    Berman M; Parameshwar J; Jenkins DP; Dhital K; Lewis C; Dempster K; Lincoln P; Sudarshan C; Large SR; Dunning J; Tsui SS
    J Thorac Cardiovasc Surg; 2010 Feb; 139(2):466-73. PubMed ID: 19833355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does total implantability reduce infection with the use of a left ventricular assist device? The LionHeart experience in Europe.
    Pae WE; Connell JM; Adelowo A; Boehmer JP; Korfer R; El-Banayosy A; Hetzer R; Vigano M; Pavie A;
    J Heart Lung Transplant; 2007 Mar; 26(3):219-29. PubMed ID: 17346623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Right heart dysfunction after left ventricular assist device implantation: a comparison of the pulsatile HeartMate I and axial-flow HeartMate II devices.
    Patel ND; Weiss ES; Schaffer J; Ullrich SL; Rivard DC; Shah AS; Russell SD; Conte JV
    Ann Thorac Surg; 2008 Sep; 86(3):832-40; discussion 832-40. PubMed ID: 18721570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ventricular assist device driveline infection: treatment with platelet-rich plasma.
    Jiritano F; Serraino GF; Rossi M; Dominijanni A; Brescia A; Renzulli A
    Ann Thorac Surg; 2013 Aug; 96(2):e37-8. PubMed ID: 23910142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of percutaneous driveline infection after left ventricular assist device implantation: prophylactic antibiotics are not necessary.
    Stulak JM; Maltais S; Cowger J; Joyce LD; Daly RC; Park SJ; Aaronson KD; Pagani FD
    ASAIO J; 2013; 59(6):570-4. PubMed ID: 24172262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of timing right ventricular assist device withdrawal using left ventricular assist device filling characteristics.
    Mandarino WA; Winowich S; Gasior TA; Pham S; Griffith BP; Kormos RL
    ASAIO J; 1997; 43(5):M801-5. PubMed ID: 9360157
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Left ventricle assist devices and driveline's infection incidence: a single-centre experience.
    Bejko J; Toto F; Gregori D; Gerosa G; Bottio T
    J Artif Organs; 2018 Mar; 21(1):52-60. PubMed ID: 28988400
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of submaximal exercise capacity in patients with left ventricular assist devices.
    Foray A; Williams D; Reemtsma K; Oz M; Mancini D
    Circulation; 1996 Nov; 94(9 Suppl):II222-6. PubMed ID: 8901750
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does continuous flow left ventricular assist device technology have a positive impact on outcome pretransplant and posttransplant?
    Klotz S; Stypmann J; Welp H; Schmid C; Drees G; Rukosujew A; Scheld HH
    Ann Thorac Surg; 2006 Nov; 82(5):1774-8. PubMed ID: 17062246
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Midterm experience with the Jarvik 2000 axial flow left ventricular assist device.
    Haj-Yahia S; Birks EJ; Rogers P; Bowles C; Hipkins M; George R; Amrani M; Petrou M; Pepper J; Dreyfus G; Khaghani A
    J Thorac Cardiovasc Surg; 2007 Jul; 134(1):199-203. PubMed ID: 17599509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of centrifugal, axial, and pulsatile left ventricular assist device support on end-organ function in heart failure patients.
    Kamdar F; Boyle A; Liao K; Colvin-adams M; Joyce L; John R
    J Heart Lung Transplant; 2009 Apr; 28(4):352-9. PubMed ID: 19332262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of left ventricular assist device therapy on ventricular arrhythmias.
    Ziv O; Dizon J; Thosani A; Naka Y; Magnano AR; Garan H
    J Am Coll Cardiol; 2005 May; 45(9):1428-34. PubMed ID: 15862414
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of APACHE II scores to select candidates for left ventricular assist device placement. Acute Physiology and Chronic Health Evaluation.
    Gracin N; Johnson MR; Spokas D; Allen J; Bartlett L; Piccione W; Parrillo JE; Costanzo MR; Calvin JE
    J Heart Lung Transplant; 1998 Oct; 17(10):1017-23. PubMed ID: 9811411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Left ventricular mechanical assist devices and cardiac device interactions: an observational case series.
    Foo D; Walker BD; Kuchar DL; Thorburn CW; Tay A; Hayward CS; Macdonald P; Keogh A; Kotlyar E; Spratt P; Jansz P
    Pacing Clin Electrophysiol; 2009 Jul; 32(7):879-87. PubMed ID: 19572863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urgent exchange of a HeartMate II left ventricular assist device after percutaneous lead fracture.
    Jafar M; Gregoric ID; Radovancevic R; Cohn WE; McGuire N; Frazier OH
    ASAIO J; 2009; 55(5):523-4. PubMed ID: 19730010
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heart transplant and left ventricular assist device costs.
    Digiorgi PL; Reel MS; Thornton B; Burton E; Naka Y; Oz MC
    J Heart Lung Transplant; 2005 Feb; 24(2):200-4. PubMed ID: 15701438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.